Smith & Nephew
From Wikipedia, the free encyclopedia
Smith & Nephew plc | |
---|---|
Type | Public (LSE: SN.) |
Founded | 1856 |
Headquarters | London |
Key people | John Buchanan, Chairman David Illingworth, CEO |
Industry | Medical devices |
Revenue | $3,369 million (2007) |
Operating income | $493 million (2007) |
Net income | $316 million (2007) |
Website | www.smith-nephew.com |
Smith & Nephew (LSE: SN.) is a British medical devices company headquartered in London and active internationally. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Smith & Nephew operates in three market segments:
- Wound management: advanced treatments for difficult wounds.
- Endoscopy: products for minimally invasive surgery.
- Orthopaedics: hip and knee implants and trauma products, based in Memphis, Tennessee.
By market capitalisation, Smith & Nephew is Europe's second-largest medical equipment firm.
[edit] Corporate history
In 1856, Thomas James Smith of Hull, Yorkshire went into business as a dispensing chemist; in 1896, he was joined by his nephew, Horatio Nelson Smith, and the business became known as T.J. Smith and Nephew.
In September 2007, Zimmer, Johnson & Johnson's DePuy Orthopaedics Inc., Smith & Nephew PLC and Biomet Inc. entered the settlement agreements, through which they will pay $300m in total, adopt industry overhauls and corporate monitoring to avoid criminal charges of conspiracy.
Smith & Nephew won Manufacturer of the Year in 2007
[edit] See also
- Taylor Spatial Frame
- Ilizarov apparatus
- Distraction osteogenesis
- Bone fracture
- Trauma surgery
- Traumatology
- External fixation
- Internal fixation
- Dynamic hip screw
- Hip fracture treatment
- Low intensity pulsed ultrasound, the technology related to healing orthopaedic nonunions
- Orthopedic surgery
- Implant (medicine)
- Arthroscopy
- Sports medicine
- Sports injuries
- Wound healing
- History of wound care
- Elastoplast
- Oxinium
- Hip resurfacing
- Hip replacement
- Knee replacement
- Joint replacement